Edition:
United States

Profile: ProMetic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

3.06CAD
22 Jul 2016
Change (% chg)

$-0.01 (-0.33%)
Prev Close
$3.07
Open
$3.05
Day's High
$3.09
Day's Low
$3.02
Volume
732,083
Avg. Vol
1,446,885
52-wk High
$3.62
52-wk Low
$1.39

ProMetic Life Sciences Inc. (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs. ProMetic is also developing its own small molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. It has research and development facilities in the United Kingdom, the United States and Canada; manufacturing facilities in the Isle of Man and Canada, and business development activities in the United States, Europe and Asia.

Company Address

ProMetic Life Sciences Inc

440 Armand-Frappier Blvd Suite 3
LAVAL   QC   H7V 4B4
P: +1450.7810115
F: +1450.7814477

Company Web Links